Dusan Trifunovic

Exciting news in the field of severe burns We're thrilled to share a fascinating case from one of our specialized CPT.Plasma.Competence.Centers at Medizinische Hochschule Hannover , recently published in the European Burns journal. The summary speaks for itself, highlighting a groundbreaking approach to burn care. Over the next few weeks, we'll dive deeper into the findings and the medical insights behind them. Stay tuned! Curious to explore the full details now? Check out the publication here: Key Highlights: "Automated large-scale CPT represents a novel and effective approach to managing burn wounds, combining #potent antimicrobial action with enhanced healing capabilities. This #dual-action makes it a valuable addition to the current therapeutic arsenal for burn care. The present case report was able to illustrate the importance in the treatment of multi-resistant colonized complex burn wounds and prove a #safe, patient #individual, #time-effective application." A big thank you to our therapy users and the dedicated authors behind this publication: Univ.Prof. Dr. med. Peter Vogt Frederik Schlottmann Vincent März Thorben Dieck Dr Moritz R. Milewski 🔗 Dive into the full article here: https://lnkd.in/gvEw6Kd7 #BurnCare #ColdPlasmaTherapy #SkinSubstitute #BurnSurgery #ClinicalInnovation #PlasticSurgery #CPT #InnovationInHealthcare #BurnCare #ColdPlasmaTherapy #MedicalBreakthroughs

8

2 Kommentare

🧠 Stroke Research in Focus: Interview with Michael Knoflach on Radio Tirol This morning, on world stroke day, Michael Knoflach, neurologist and scientist at VASCage GmbH and the Medical University of Innsbruck, shared exciting insights into stroke detection, prevention research, and clinical studies at VASCage! 🎙️🩺 In his Radio Tirol interview (Hallo Tirol, from 8:10 a.m.), Michael covers: 🔹 The latest methods for early stroke detection 🔹 Prevention strategies that reduce risks 🔹 clinical trials on prevention for the general public For those who missed it, you can listen to the interview here: [tirol.orf.at] #clinicaltrial #stroke #WSD2024

64

🦶 Hintermann Series H2 | Total Ankle Replacement The Hintermann Series H2® is indicated as a total ankle replacement (TAR) in primary or revision surgery of ankle joints damaged by: Systemic arthritis of the ankle (e.g., rheumatoid arthritis, hemochromatosis), Primary arthritis (e.g., de-generative disease), Secondary arthritis (e.g., post-traumatic, avascular necrosis, provided enough of the talus is preserved to support the implant). The Hintermann Series H2 is also indicated for patients with a failed previous ankle surgery and revision surgeries following failed total ankle replacement or non-union/mal-union of an ankle arthrodesis, provided sufficient bone stock is present. Learn More ℹ️ https://lnkd.in/ei_-Yayc

44

🦶 Hintermann Series H2 | Total Ankle Replacement The Hintermann Series H2® is indicated as a total ankle replacement (TAR) in primary or revision surgery of ankle joints damaged by: Systemic arthritis of the ankle (e.g., rheumatoid arthritis, hemochromatosis), Primary arthritis (e.g., de-generative disease), Secondary arthritis (e.g., post-traumatic, avascular necrosis, provided enough of the talus is preserved to support the implant). The Hintermann Series H2 is also indicated for patients with a failed previous ankle surgery and revision surgeries following failed total ankle replacement or non-union/mal-union of an ankle arthrodesis, provided sufficient bone stock is present. Learn More ℹ️ https://lnkd.in/ei_-Yayc

47

1 Kommentar

🚨 Breaking News in Cardiac Diagnostics! 🚨 The Gemeinsame Bundesausschuss (G-BA) has officially endorsed Cardiac Magnetic Resonance Imaging (CMR) as the primary diagnostic tool for suspected myocarditis cases! 🫀✨ Key Highlights: - CMR will be the go-to method for patients who are hemodynamically stable. - Endomyocardial biopsy remains essential for complex cases. - Future guidelines will standardize CMR's use in clinical settings. While CMR shines in diagnosis, it won't be used for ongoing monitoring of established myocarditis just yet. This strategic decision ensures that healthcare providers utilize evidence-based practices, enhancing patient care. Stay tuned as the G-BA initiates a formal consultation process to develop comprehensive guidelines that will shape cardiac care standards moving forward. 👉 Click the link to learn more about this pivotal development and its implications for healthcare professionals! #CMR #Cardiology #ClinicalResearches #G-BA #HealthcareInnovation #MedicalGuidelines #Myocarditis #RegulatoryAgencies #MarketAccess #MarketAccessToday

1

1 Kommentar

📰 [ARTICLE] Retrospective analysis of German health data reveal that switching to a different mask type or supplying a replacement mask improved adherence to #positiveairwaypressure therapy in people with suboptimal usage (<4 h/night) 👉 https://lnkd.in/euar8BZE For more expert insights into sleep and breathing health topics and the latest scientific articles, follow Clinical Respiratory News today!

52

1 Kommentar

Dive into the discussion on when to say "no" to ambulatory anesthesia. Dr. BobbieJean Sweitzer shares her insights on the Top 10 reasons to reconsider providing anesthesia in outpatient settings. Read the article here: https://zurl.co/6946 #AmbulatoryAnesthesia #AneScan

1

🌟 Clinical case spotlight: Comparison of the same breast, two years apart, reveals carcinoma 🌟 This real-life example highlights the power of nu:view Breast CT in everyday use. ✦ A patient returned to MVZ Prof. Dr. Uhlenbrock und Partner in Dortmund for a follow-up scan (without contrast media) two years after her initial breast CT examination. ✦ Even with this non-contrast scan, the changes over the two years in the breast are clearly visible in the high-resolution images. A malignant tumor was identified in the upper outer quadrant of the breast. ✦ This case underscores the vital importance of regular check-ups and the critical role that nu:view plays in early and precise diagnosis. We send our best wishes to the patient for a successful treatment and recovery. Special thanks to Dr.med. Karsten Ridder for sharing this valuable example from his daily practice. 📹Watch the entire video for more details. #BreastCT #MammaCT #ABCT 

48

5 Kommentare

#ECIOtakeover with Prof. Heiko Alfke Football is a somewhat serious issue in our department. After the weekend the recent results of the “Bundesliga” and other football leagues are intensively discussed. Here are some strong supporters of football clubs from our department. #imaging #radiology #healthcare #IRtrainees #Medicalstudents #medstudent

17

3 Kommentare

🌟 Mastering Dexter 🌟 Dr. Gantner and Dr. Seeger from Kantonsspital Winterthur share their insights on mastering the #Dexter Surgical System. Learn more here: https://lnkd.in/dyuVrqEa 🔹 Dr. Lukas Gantner: "The learning curve was relatively quick and pleasant. Dexter's system is very close to traditional laparoscopy, making it easy to adapt while ensuring safety and quality." 🔹 Dr. Nico Seeger: "The learning curve for Dexter is quicker compared to laparoscopy because of our prior experience. The transition is smooth as many techniques remain the same.” #Surgery #Innovation #RoboticSurgery #Laparoscopy #HealthcareInnovation #MedicalTechnology #DexterSurgery #CantonalHospitalWinterthur #distalmotion #accessiblity #excellence #simplicity

109

3 Kommentare

You can read one of the reasons for our true clean label philosophy here. #truecleanlabel

11

📢 #specialissue #CallforPapers Oncologie new special issue“Cancer as a Metabolic Disease – Therapeutic Implications of a New Paradigm”is open for submission now. 📆 Submission Deadline:   15 February 2025 👨‍🎓 Guest Editors PD Dr. Rainer J. Klement, Department of Radiation Oncology, Leopoldina Hospital Schweinfurt, Germany Prof. Dr. Thomas N. Seyfried, Department of Biology, Boston College, Chestnut Hill, MA 02467, USA 📝 The editors welcome the submission of original research and review papers, commentaries and case reports on all aspects of altered cancer cell metabolism and how it could be targeted.This includes, but is not limited to: • The theoretical basis of altered tumor cell metabolism (e.g., cancer as an evolutionary reversal, virus-induced changes in cell metabolism) • Metabolic indicators and their application for tumor diagnostics and staging • Mito-nuclear crosstalk and the relationship between metabolic regulation and genetic/gene regulation • Clinical and preclinical application of metabolic inhibitors (2-DG, DCA, metformin, curcumin, etc.) • Nutritional interventions (e.g., fasting, calorie restriction, ketogenic diet) • Pro-oxidative therapies (e.g., hyperthermia, high-dose vitamin C, HBOT, etc.) • Resistance training in cancer treatment • Metabolic effects of psycho-social interventions • Synergy between metabolic therapies and conventional treatments 📚 Please submit your manuscript until 15-Februaray-2025 to https://lnkd.in/gqcJnyRs

3

What will future therapies for neurological conditions such as stroke look like? In this captivating article, Martin Schuettler, Chief Technology Officer of CorTec GmbH, walks Open Access Government through a groundbreaking achievement in developing new treatments for neurological conditions. Read in full here: https://bit.ly/3xtFi5v #StrokeTreatments #MedicalTreatment #NeurologicialConditions

17

2 Kommentare

Brain Interchange for the Future of Therapies! After the recent FDA approval for the IDE study with our Brain Interchange system(https://lnkd.in/eapsHsJx), we are now entering the next phase. In a couple of weeks, the research team at the University of Washington will start investigating their novel and very promising way to improve the outcome of rehabilitation after stroke, applying fast closed-loop brain stimulation using our implantable Brain-Computer Interface - the Brain Interchange. This will open up new possibilities for stroke rehabilitation therapy approaches and we are very proud to be able to contribute to these important milestones. With the research into stroke therapy, a new chapter is beginning for us and we will continue to support further projects for the development of therapies for various indications. In the last publication in the Open Access Government magazine, Martin Schuettler gives a valuable insight into the #future of the therapies that we will be shaping together with our partners and our unique Brain Interchange System. #BCI #BrainComputerInterface #Neuromodulation #BrainInterchange #FutureTherapies #ClinicalStudy

48

🌟 New Case Study - Osteochondral lesion of the talar shoulder 🌟 Check out the #ONcase by Markus Walther from Schön Klinik Gruppe, Munich. Learn from a F&A expert as he discusses a case of a young patient with chronic pain following a sprained ankle and how he managed it. Watch here: https://lnkd.in/eF2AbdxJ ON Foundation #orthopedics #orthoregeneration

20

❓ Are you afraid of joint replacement surgery? Prof. Dr. med. Oliver Hauschild talks about whether you should be afraid of endoprosthetic surgery. You can watch an exclusive interview with the doctor on our YouTube channel: https://bit.ly/3pj41p0 #BookingHealth #askthedoctor #hip #joint #endoprostheses

7

✨ 𝐀𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐦𝐞𝐧𝐭 ✨ We are happy to welcome the Kopfwehzentrum Hirslanden & Neurologica as an #early #adopter of our Priority Access Program for #migraine patients! 🚀   Through this program, we are providing our personalized neurostimulators to selected #neuro #clinics for use in patients. 🧠   Located in Zürich, the 𝐊𝐨𝐩𝐟𝐰𝐞𝐡𝐳𝐞𝐧𝐭𝐫𝐮𝐦 𝐇𝐢𝐫𝐬𝐥𝐚𝐧𝐝𝐞𝐧 𝐢𝐬 𝐚 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐧𝐞𝐮𝐫𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐜𝐨𝐦𝐩𝐞𝐭𝐞𝐧𝐜𝐞 𝐜𝐞𝐧𝐭𝐞𝐫: • 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐧𝐠 𝐚𝐧𝐝 𝐭𝐫𝐞𝐚𝐭𝐢𝐧𝐠 𝐨𝐯𝐞𝐫 𝟑𝟎𝟎 𝐭𝐲𝐩𝐞𝐬 𝐨𝐟 𝐡𝐞𝐚𝐝𝐚𝐜𝐡𝐞𝐬, including migraines, tension headaches, cluster headaches, and trauma-induced headaches, as well as general neurological conditions such as multiple sclerosis (MS), stroke, muscle and nerve disorders, epilepsy, sleep disorders, dementia and movement disorders. • 𝐑𝐞𝐧𝐨𝐰𝐧𝐞𝐝 𝐟𝐨𝐫 𝐩𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐜𝐚𝐫𝐞, offering tailored diagnostic and therapeutic pathways to improve patients' quality of life sustainably. • 𝐄𝐪𝐮𝐢𝐩𝐩𝐞𝐝 𝐰𝐢𝐭𝐡 𝐬𝐭𝐚𝐭𝐞-𝐨𝐟-𝐭𝐡𝐞-𝐚𝐫𝐭 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲, such as ENMG, EEG, neurovascular ultrasound, and access to top-tier MRI radiology networks.   With its unparalleled specialization in headache disorders, innovative diagnostic approaches, and commitment to tailored, long-term treatment solutions, the Kopfwehzentrum Hirslanden stands out as an exceptional collaborator for this initiative.   💡 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐨𝐟 𝐨𝐮𝐫 𝐌𝐢𝐚𝐦𝐢𝐧𝐝® 𝐍𝐞𝐮𝐫𝐨𝐬𝐭𝐢𝐦𝐮𝐥𝐚𝐭𝐨𝐫𝐬: • 𝐏𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝: Each device is tailored to the patient’s specific MRI data. The therapy plan is created after prescription and target region definition by the expert. • 𝐍𝐨𝐧-𝐢𝐧𝐯𝐚𝐬𝐢𝐯𝐞: Transcranial stimulation (tCS) offers a safe, non-invasive alternative to treatments with reduced risks, according to current research. • 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜𝐚𝐥𝐥𝐲 𝐛𝐚𝐜𝐤𝐞𝐝: The benefits of tCS are grounded in extensive research and clinical studies.   Together, we aim to redefine migraine treatment and improve patient outcomes with innovative, precision-driven neurotechnology. A heartfelt thank you to the entire team at the Kopfwehzentrum Hirslanden for your trust and collaboration in pioneering this groundbreaking program. 🙌   📩 𝐏𝐥𝐞𝐚𝐬𝐞 𝐜𝐨𝐧𝐭𝐚𝐜𝐭 Bottneuro AG 𝐨𝐫 𝐭𝐡𝐞 Kopfwehzentrum Hirslanden & Neurologica 𝐡𝐞𝐫𝐞: https://lnkd.in/e86fK9ZT 𝐢𝐟 𝐲𝐨𝐮 𝐰𝐚𝐧𝐭 𝐭𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐩𝐢𝐥𝐨𝐭 𝐩𝐫𝐨𝐠𝐫𝐚𝐦.   🌟 #neurology #neurotec #neurostimulation #earlyadopters #swiss #precisionmedicine 🌟

52

2 Kommentare